Perspective: The case for an evidence-based reference interval for serum magnesium: The time has come

Advances in Nutrition

Volumn 7, Issue 6, 2016, Pages 977-993

  Costello, Rebecca B ^a   Elin, Ronald J ^b   Rosanoff, Andrea ^a   Wallace, Taylor C ^c   Guerrero Romero, Fernando ^d   Hruby, Adela ^e   Lutsey, Pamela L ^f   Nielsen, Forrest H ^g   Rodriguez Moran, Martha ⁱ   Song, Yiqing ^g   Van Horn, Linda V ^h  

^a Center for Magnesium Education and Research   (United States)

^b University of Louisville School of Medicine   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e TUFTS UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^h INDIANA UNIVERSITY   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chronic disease; Magnesium deficiency; Plasma magnesium; Reference interval; Serum magnesium

Indexed keywords

MAGNESIUM;

ANIMAL; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; HUMAN; INFLAMMATION; MAGNESIUM DEFICIENCY; METABOLIC DISEASES; MUSCULOSKELETAL DISEASES; NERVOUS SYSTEM DISEASES; NUTRITION POLICY; NUTRITIONAL ASSESSMENT; NUTRITIONAL REQUIREMENT; REFERENCE VALUE; URINE;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; MAGNESIUM; MAGNESIUM DEFICIENCY; METABOLIC DISEASES; MUSCULOSKELETAL DISEASES; NERVOUS SYSTEM DISEASES; NUTRITION ASSESSMENT; NUTRITION POLICY; NUTRITIONAL REQUIREMENTS; REFERENCE VALUES;

EID: 84997207644     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.116.012765     Document Type: Article

References (185)

1. Moshfegh A, Goldman JD, Ahuja J, Rhodes D, LaComb R. What we eat in America, NHANES 2005-2006: usual nutrient intakes from food and water compared to 1997 Dietary Reference Intakes for vitamin D, calcium, phosphorus, and magnesium. Washington (DC): USDA; 2009.
2. US Department of Health and Human Services. Scientific report of the 2015 Dietary Guidelines Advisory Committee [Internet]. [cited 2015 Oct 1]. Available from: http://health.gov/dietaryguidelines/2015-scientific-report.
3. European Food Safety Authority. Scientific opinion on dietary reference values for magnesium. EFSA J 2015;13:4186.
4. Jee SH, Miller ER III, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 2002;15:691-6.
5. Dickinson HO, Nicolson DJ, Campbell F, Cook JV, Beyer FR, Ford GA, Mason J. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev 2006;3:CD004640.
6. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012;66:411-8.
7. Rosanoff A. Magnesium supplements may enhance the effect of antihypertensive medications in stage 1 hypertensive subjects. Magnes Res 2010;23:27-40.
8. Rosanoff A, Plesset MR. Oral magnesium supplements decrease high blood pressure (SBP > 155 mmHg) in hypertensive subjects on antihypertensive medications: a targeted meta-analysis. Magnes Res 2013;26:93-9.
9. Zhang X, Li Y, Del Gobbo LC, Rosanoff A, Wang J, Zhang W, Song Y. Effects of magnesium supplementation on blood pressure: a metaanalysis of randomized double-blind placebo-controlled trials. Hypertension 2016;68:324-33.
10. Del Gobbo LC, Imamura F, Wu JH, de Oliveira Otto MC, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 2013;98:160-73.
11. Joosten MM, Gansevoort RT, Mukamal KJ, van der Harst P, Geleijnse JM, Feskens EJ, Navis G, Bakker SJ. Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr 2013;97:1299-306.
12. Seelig MS, Elin RJ, Antman EM. Magnesium in acute myocardial infarction: still an open question. Can J Cardiol 1998;14:745-9.
13. Shlezinger M, Amitai Y, Goldenberg I, Shechter M. Desalinated seawater supply and all-cause mortality in hospitalized acute myocardial infarction patients from the Acute Coronary Syndrome Israeli Survey 2002-2013. Int J Cardiol 2016;220:544-50.
14. Song Y, Manson JE, Cook NR, Albert CM, Buring JE, Liu S. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol 2005;96:1135-41.
15. He K, Song Y, Belin RJ, Chen Y. Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J Cardiometab Syndr 2006;1:351-5.
16. Ford ES, Li C, McGuire LC, Mokdad AH, Liu S. Intake of dietary magnesium and the prevalence of the metabolic syndrome among U.S. adults. Obesity (Silver Spring) 2007;15:1139-46.
17. Rodríguez-Moran M, Simental Mendia LE, Zambrano Galvan G, Guerrero-Romero F. The role of magnesium in type 2 diabetes: a brief based-clinical review. Magnes Res 2011;24:156-62.
18. Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 2011;34:2116-22.
19. Rude RK, Singer FR, Gruber HE. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009;28:131-41.
20. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 1999;69:727-36.
21. Lowenstein FW, Stanton MF. Serum magnesium levels in the United States, 1971-1974. J Am Coll Nutr 1986;5:399-414.
22. Lundberg GD. Medscape editorial on magnesium [Internet]. [cited 2016 Jul 6]. Available from: http://www.medscape.com/viewarticle/844214.
23. Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res 2010;23:S194-8.
24. Ismail Y, Ismail AA, Ismail AA. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for "normal" results. Clin Chem Lab Med 2010;48:323-7.
25. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J 2012;5(Suppl 1):i3-14.
26. Ayuk J, Gittoes NJ. Contemporary view of the clinical relevance of magnesium homeostasis. Ann Clin Biochem 2014;51:179-88.
27. Arnaud MJ. Update on the assessment of magnesium status. Br J Nutr 2008;99(Suppl 3):S24-36.
28. Lameris AL, Monnens LA, Bindels RJ, Hoenderop JG. Druginduced alterations in Mg2+ homoeostasis. Clin Sci (Lond) 2012; 123:1-14.
29. WitkowskiM, Hubert J, Mazur A. Methods of assessment of magnesium status in humans: a systematic review. Magnes Res 2011;24:163-80.
30. Lakshmanan FL, Rao RB, Kim WW, Kelsay JL. Magnesium intakes, balances and blood levels of adults consuming self-selected diets. Am J Clin Nutr 1984;40:1380-9.
31. Hunt CD, Johnson LK. Magnesium requirements: new estimations for men and women by cross-sectional statistical analyses of metabolic magnesium balance data. Am J Clin Nutr 2006;84:843-52.
32. Anke M, Glei M, Vormann J, Müller R, Hoppe C, Schäfer U. Magnesium in the nutrition of man. In: Porr PJ, Nechifor M, Durlach J, editors. Advances in magnesium research: new data. Montrouge (France): John Libbey Eurotext; 2006. p. 175-86.
33. Palacios C, Wigertz K, Braun M, Martin BR, McCabe GP, McCabe L, Pratt JH, Peacock M, Weaver CM. Magnesium retention from metabolicbalance studies in female adolescents: impact of race, dietary salt, and calcium. Am J Clin Nutr 2013;97:1014-9.
34. Nielsen FH. Magnesium, inflammation, and obesity in chronic disease. Nutr Rev 2010;68:333-40.
35. Nielsen FH, Milne DB. A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women. Eur J Clin Nutr 2004;58:703-10.
36. Volpe SL. Magnesium. In: Erdman JWJ, Macdonald EA, Zeisel SH, editors. Present knowledge in nutrition. 10th ed. Oxford (United Kingdom): Wiley-Blackwell; 2012: p. 459-74.
37. Rude RK, Shils ME. Magnesium. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RI, editors. Modern nutrition in health and disease. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 223-47.
38. Coudray C, Demigne C, Rayssiguier Y. Effects of dietary fibers on magnesium absorption in animals and humans. J Nutr 2003;133:1-4.
39. Nielsen FH, Milne DB, Gallagher S, Johnson L, Hoverson B. Moderate magnesium deprivation results in calcium retention and altered potassium and phosphorus excretion by postmenopausal women. Magnes Res 2007;20:19-31.
40. Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L. Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. J Am Coll Nutr 2007;26:121-32.
41. Nielsen FH, Milne DB. Some magnesium status indicators and oxidative metabolism responses to low-dietary magnesium are affected by dietary copper in postmenopausal women. Nutrition 2003;19:617-26.
42. Lukaski HC, Nielsen FH. Dietary magnesium depletion affects metabolic responses during submaximal exercise in postmenopausal women. J Nutr 2002;132:930-5.
43. Malpuech-Brugère C, Nowacki W, Daveau M, Gueux E, Linard C, Rock E, Lebreton J, Mazur A, Rayssiguier Y. Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta 2000;1501:91-8.
44. Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F, Wallace R, Liu S. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010;33:304-10.
45. Simental-Mendía LE, Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial. Arch Med Res 2014;45:325-30.
46. Romani AM. Magnesium in health and disease. Met Ions Life Sci 2013;13:49-79.
47. Rude RK, Gruber HE. Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem 2004;15:710-6.
48. Rude RK, Gruber HE, Norton HJ, Wei LY, Frausto A, Kilburn J. Reduction of dietary magnesium by only 50% in the rat disrupts bone and mineral metabolism. Osteoporos Int 2006;17:1022-32.
49. Zheng J, Mao X, Ling J, He Q, Quan J, Jiang H. Association between serum level of magnesium and postmenopausal osteoporosis: a metaanalysis. Biol Trace Elem Res 2014;159:8-14.
50. Reginster JY, Strause L, Deroisy R, Lecart MP, Saltman P, Franchimont P. Preliminary report of decreased serum magnesium in postmenopausal osteoporosis. Magnesium 1989;8:106-9.
51. Gür A, Colpan L, Nas K, Cevik R, Sarac J, Erdogan F, Duz MZ. The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin. J Bone Miner Metab 2002;20:39-43.
52. Mutlu M, Argun M, Kilic E, Saraymen R, Yazar S. Magnesium, zinc and copper status in osteoporotic, osteopenic and normal post-menopausal women. J Int Med Res 2007;35:692-5.
53. Liu SZ, Yan H, Xu P, Li JP, Zhuang GH, Zhu BF, Lu SM. Correlation analysis between bone mineral density and serum element contents of postmenopausal women in Xi'an urban area. Biol Trace Elem Res 2009;131:205-14.
54. Haliloglu B, Aksungar FB, Ilter E, Peker H, Akin FT, Mutlu N, Ozekici U. Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women. Arch Gynecol Obstet 2010;281:663-8.
55. Okyay E, Ertugrul C, Acar B, Sisman AR, Onvural B, Ozaksoy D. Comparative evaluation of serum levels of main minerals and postmenopausal osteoporosis. Maturitas 2013;76:320-5.
56. Aydin H, Deyneli O, Yavuz D, Gozu H, Mutlu N, Kaygusuz I, Akalin S. Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Biol Trace Elem Res 2010;133:136-43.
57. Dimai HP, Porta S, Wirnsberger G, Lindschinger M, Pamperl I, Dobnig H, Wilders-Truschnig M, Lau KH. Daily oral magnesium supplementation suppresses bone turnover in young adult males. J Clin Endocrinol Metab 1998;83:2742-8.
58. Hayhoe RP, Lentjes MA, Luben RN, Khaw KT, Welch AA. Dietary magnesium and potassium intakes and circulating magnesium are associated with heel bone ultrasound attenuation and osteoporotic fracture risk in the EPIC-Norfolk cohort study. Am J Clin Nutr 2015;102:376-84.
59. Odabasi E, Turan M, Aydin A, Akay C, Kutlu M. Magnesium, zinc, copper, manganese, and selenium levels in postmenopausal women with osteoporosis. Can magnesium play a key role in osteoporosis? Ann Acad Med Singapore 2008;37:564-7.
60. Nielsen FH, Lukaski HC, Johnson LK, Roughead ZK. Reported zinc, but not copper, intakes influence whole-body bone density, mineral content and T score responses to zinc and copper supplementation in healthy postmenopausal women. Br J Nutr 2011;106:1872-9.
61. Orchard TS, Larson JC, Alghothani N, Bout-Tabaku S, Cauley JA, Chen Z, LaCroix AZ, Wactawski-Wende J, Jackson RD. Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study. Am J Clin Nutr 2014;99:926-33.
62. Tucker KL, Hannan MT, Kiel DP. The acid-base hypothesis: diet and bone in the Framingham Osteoporosis Study. Eur J Nutr 2001;40:231-7.
63. Angus RM, Sambrook PN, Pocock NA, Eisman JA. Dietary intake and bone mineral density. Bone Miner 1988;4:265-77.
64. Yano K, Heilbrun LK, Wasnich RD, Hankin JH, Vogel JM. The relationship between diet and bone mineral content of multiple skeletal sites in elderly Japanese-American men and women living in Hawaii. Am J Clin Nutr 1985;42:877-88.
65. Ilich JZ, Brownbill RA, Tamborini L. Bone and nutrition in elderly women: protein, energy, and calcium as main determinants of bone mineral density. Eur J Clin Nutr 2003;57:554-65.
66. Stendig-Lindberg G, Tepper R, Leichter I. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res 1993;6:155-63.
67. Abraham GE, Grewal H. A total dietary program emphasizing magnesium instead of calcium. Effect on the mineral density of calcaneous bone in postmenopausal women on hormonal therapy. J Reprod Med 1990;35:503-7.
68. Ryder KM, Shorr RI, Bush AJ, Kritchevsky SB, Harris T, Stone K, Cauley J, Tylavsky FA. Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects. J Am Geriatr Soc 2005;53:1875-80.
69. Zhang X, Xia J, Del Gobbo LC, Hruby A, He K, Dai Q, Song Y. Serum magnesium and mortality in the general US population: results from the NHANES I Epidemiologic Follow-Up Study. Circulation 2016;133 (Suppl 1):AP146.
70. Mejía-Rodriguez F, Shamah-Levy T, Villalpando S, Garcia-Guerra A, Mendez-Gomez Humaran I. Iron, zinc, copper and magnesium deficiencies in Mexican adults from the National Health and Nutrition Survey 2006. Salud Publica Mex 2013;55:275-84.
71. De la Cruz-Góngora V, Gaona B, Villalpando S, Shamah-Levy T, Robledo R. Anemia and iron, zinc, copper and magnesium deficiency in Mexican adolescents: National Health and Nutrition Survey 2006. Salud Publica Mex 2012;54:135-45.
72. Morales-Ruán Mdel C, Villalpando S, Garcia-Guerra A, Shamah-Levy T, Robledo-Perez R, Avila-Arcos MA, Rivera JA. Iron, zinc, copper and magnesium nutritional status in Mexican children aged 1 to 11 years. Salud Publica Mex 2012;54:125-34.
73. Zhan Y, Chen R, Zheng W, Guo C, Lu L, Ji X, Chi Z, Yu J. Association between serum magnesium and anemia: china health and nutrition survey. Biol Trace Elem Res 2014;159:39-45.
74. Akizawa Y, Koizumi S, Itokawa Y, Ojima T, Nakamura Y, Tamura T, Kusaka Y. Daily magnesium intake and serum magnesium concentration among Japanese people. J Epidemiol 2008;18:151-9.
75. Ghasemi A, Syedmoradi L, Zahediasl S, Azizi F. Pediatric reference values for serum magnesium levels in Iranian subjects. Scand J Clin Lab Invest 2010;70:415-20.
76. Jagarinec N, Flegar-Mestric Z, Surina B, Vrhovski-Hebrang D, Preden-Kerekovic V. Pediatric reference intervals for 34 biochemical analytes in urban school children and adolescents. Clin Chem Lab Med 1998;36:327-37.
77. Jose B, Jain V, Vikram NK, Agarwala A, Saini S. Serum magnesium in overweight children. Indian Pediatr 2012;49:109-12.
78. Chang X, Li J, Guo Y, Wei Z, Mentch FD, Hou C, Zhao Y, Qiu H, Kim C, Sleiman PM, et al. Genome-wide association study of serum minerals levels in children of different ethnic background. PLoS One 2015;10:e0123499.
79. Shibutani Y, Sakamoto K, Katsuno S, Yoshimoto S, Matsuura T. Relation of serum and erythrocyte magnesium levels to blood pressure and a family history of hypertension. A follow-up study in Japanese children, 12-14 years old. Acta Paediatr Scand 1990;79:316-21.
80. Wörwag M, Classen HG, Schumacher E. Prevalence of magnesium and zinc deficiencies in nursing home residents in Germany. Magnes Res 1999;12:181-9.
81. Carlsson L, Lind L, Larsson A. Reference values for 27 clinical chemistry tests in 70-year-old males and females. Gerontology 2010;56: 259-65.
82. Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A. Essential arterial hypertension and stone disease. Kidney Int 1999;55:2397-406.
83. Ghasemi A, Zahediasl S, Syedmoradi L, Azizi F. Low serum magnesium levels in elderly subjects with metabolic syndrome. Biol Trace Elem Res 2010;136:18-25.
84. Guerrero-Romero F, Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002;39:209-13.
85. Guerrero-Romero F, Rodriguez-Moran M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord 2002;26:469-74.
86. Guerrero-Romero F, Rodriguez-Moran M. Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects. Eur J Intern Med 2013;24:639-43.
87. Panhwar AH, Kazi TG, Afridi HI, Talpur FN, Arain S, Kazi N. Distribution of potassium, calcium, magnesium, and sodium levels in biological samples of Pakistani hypertensive patients and control subjects. Clin Lab 2014;60:463-74.
88. Rasic-Milutinovic Z, Perunicic-Pekovic G, Jovanovic D, Gluvic Z, Cankovic-Kadijevic M. Association of blood pressure and metabolic syndrome components with magnesium levels in drinking water in some Serbian municipalities. J Water Health 2012;10:161-9.
89. Yu Y, Cai Z, Zheng J, Chen J, Zhang X, Huang XF, Li D. Serum levels of polyunsaturated fatty acids are low in Chinese men with metabolic syndrome, whereas serum levels of saturated fatty acids, zinc, and magnesium are high. Nutr Res 2012;32:71-7.
90. Guerrero-Romero F, Rascon-Pacheco RA, Rodriguez-Moran M, de la Pena JE, Wacher N. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest 2008;38:389-96.
91. Randell EW, Mathews M, Gadag V, Zhang H, Sun G. Relationship between serum magnesium values, lipids and anthropometric risk factors. Atherosclerosis 2008;196:413-9.
92. Rodríguez-Moran M, Guerrero-Romero F. Insulin secretion is decreased in non-diabetic individuals with hypomagnesaemia. Diabetes Metab Res Rev 2011;27:590-6.
93. Rotter I, Kosik-Bogacka D, Dolegowska B, Safranow K, Karakiewicz B, Laszczynska M. Relationship between serum magnesium concentration and metabolic and hormonal disorders in middle-aged and older men. Magnes Res 2015;28:99-107.
94. Sharifi F, Mazloomi S, Hajihosseini R, Mazloomzadeh S. Serum magnesium concentrations in polycystic ovary syndrome and its association with insulin resistance. Gynecol Endocrinol 2012;28:7-11.
95. Sharma A, Dabla S, Agrawal RP, Barjatya H, Kochar DK, Kothari RP. Serum magnesium: an early predictor of course and complications of diabetes mellitus. J Indian Med Assoc 2007;105:16.
96. Syedmoradi L, Ghasemi A, Zahediasl S, Azizi F. Prevalence of hypoand hypermagnesemia in an Iranian urban population. Ann Hum Biol 2011;38:150-5.
97. Johnson MA, Dooley SP, Caster WO, Ham CG. The relationship between dietary calcium and blood pressure in the elderly. J Clin Exp Gerontol 1987;9:89-102.
98. Kesteloot H, Tzoulaki I, Brown IJ, Chan Q, Wijeyesekera A, Ueshima H, Zhao L, Dyer AR, Unwin RJ, Stamler J, et al. Relation of urinary calcium and magnesium excretion to blood pressure: the International Study Of Macro-And Micro-nutrients and Blood Pressure and the International Cooperative Study on Salt, Other Factors, and Blood Pressure. Am J Epidemiol 2011;174:44-51.
99. Yamori Y, Sagara M, Mizushima S, Liu L, Ikeda K, Nara Y. An inverse association between magnesium in 24-h urine and cardiovascular risk factors in middle-aged subjects in 50 CARDIAC Study populations. Hypertens Res 2015;38:219-25.
100. Yamamoto ME, ApplegateWB, Klag MJ, Borhani NO, Cohen JD, Kirchner KA, Lakatos E, Sacks FM, Taylor JO, Hennekens CH. Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Ann Epidemiol 1995;5:96-107.
101. Chacko SA, Sul J, Song Y, Li X, LeBlanc J, You Y, Butch A, Liu S. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals. Am J Clin Nutr 2011;93:463-73.
102. Doyle L, Flynn A, Cashman K. The effect of magnesium supplementation on biochemical markers of bone metabolism or blood pressure in healthy young adult females. Eur J Clin Nutr 1999;53:255-61.
103. Fu ZY, Yang FL, Hsu HW, Lu YF. Drinking deep seawater decreases serum total and low-density lipoprotein-cholesterol in hypercholesterolemic subjects. J Med Food 2012;15:535-41.
104. Guerrero-Romero F, Simental-Mendía LE, Hernández-Ronquillo G, Rodriguez-Morán M. Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: a double-blind placebo-controlled randomized trial. Diabetes Metab 2015;41:202-7.
105. Itoh K, Kawasaka T, Nakamura M. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr 1997;78:737-50.
106. Lee S, Park HK, Son SP, Lee CW, Kim IJ, Kim HJ. Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults. Nutr Metab Cardiovasc Dis 2009;19:781-8.
107. Lima de Souza E, Cruz T, Rodrigues LE, Ladeia AM, Bomfim O, Olivieri L, Melo J, Correia R, Porto M, Cedro A. Magnesium replacement does not improve insulin resistance in patients with metabolic syndrome: a 12-week randomized double-blind study. J ClinMed Res 2014;6:456-62.
108. Resnick LM, Oparil S, Chait A, Haynes RB, Kris-Etherton P, Stern JS, Clark S, Holcomb S, Hatton DC, Metz JA, et al. Factors affecting blood pressure responses to diet: the Vanguard study. Am J Hypertens 2000;13:956-65.
109. Shechter M, Saad T, Shechter A, Koren-Morag N, Silver BB, Matetzky S. Comparison of magnesium status using X-ray dispersion analysis following magnesium oxide and magnesium citrate treatment of healthy subjects. Magnes Res 2012;25:28-39.
110. Carpenter TO, DeLucia MC, Zhang JH, Bejnerowicz G, Tartamella L, Dziura J, Petersen KF, Befroy D, Cohen D. A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls. J Clin Endocrinol Metab 2006;91:4866-72.
111. Guerrero-Romero F, Tamez-Perez HE, González-González G, Salinas-Martínez AM, Montes-Villarreal J, Treviño-Ortiz JH, Rodríguez-Morán M. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004;30:253-8.
112. Guerrero-Romero F, Rodríguez-Morán M. Magnesium improves the beta-cell function to compensate variation of insulin sensitivity: double-blind, randomized clinical trial. Eur J Clin Invest 2011;41:405-10.
113. Held K, Antonijevic IA, Kunzel H, Uhr M, Wetter TC, Golly IC, Steiger A, Murck H. Oral Mg(2+) supplementation reverses agerelated neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry 2002;35:135-43.
114. Mooren FC, Kruger K, Volker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in nondiabetic subjects-a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab 2011;13:281-4.
115. Nielsen FH, Johnson LK, Zeng H. Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep. Magnes Res 2010;23:158-68.
116. Sacks FM, Willett WC, Smith A, Brown LE, Rosner B, Moore TJ. Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake. Hypertension 1998;31:131-8.
117. Sur G, Maftel O. Role of magnesium in essential hypertension in teenagers. In: Porr PJ, Nechifor M, Durlach J, editors. Advances in magnesium research: new data. Montrouge (France): John Libbey Eurotext; 2006. p. 55-9.
118. Cosaro E, Bonafini S, Montagnana M, Danese E, Trettene MS, Minuz P, Delva P, Fava C. Effects of magnesium supplements on blood pressure, endothelial function and metabolic parameters in healthy young men with a family history of metabolic syndrome. Nutr Metab Cardiovasc Dis 2014;24:1213-20.
119. Lichodziejewska B, Klos J, Rezler J, Grudzka K, Dluzniewska M, Budaj A, Ceremuzynski L. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol 1997;79:768-72.
120. Paolisso G, Sgambato S, Gambardella A, Pizza G, Tesauro P, Varricchio M, D'Onofrio F. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 1992;55:1161-7.
121. Rodriguez-Hernandez H, Cervantes-Huerta M, Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation decreases alanine aminotransferase levels in obese women. Magnes Res 2010;23:90-6.
122. Rodríguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Arch Med Res 2014;45:388-93.
123. Simental-Mendía LE, Rodríguez-Moran M, Reyes-Romero MA, Guerrero-Romero F. No positive effect of oral magnesium supplementation in the decreases of inflammation in subjects with prediabetes: a pilot study. Magnes Res 2012;25:140-6.
124. Wary C, Brillault-Salvat C, Bloch G, Leroy-Willig A, Roumenov D, Grognet JM, Leclerc JH, Carlier PG. Effect of chronic magnesium supplementation on magnesium distribution in healthy volunteers evaluated by 31P-NMRS and ion selective electrodes. Br J Clin Pharmacol 1999;48:655-62.
125. Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 1995;39:217-23.
126. Barragán-Rodríguez L, Rodríguez-Morán M, Guerrero-Romero F. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res 2008;21:218-23.
127. Bashir Y, Sneddon JF, Staunton HA, Haywood GA, Simpson IA, McKenna WJ, Camm AJ. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol 1993;72:1156-62.
128. Barbagallo M, Dominguez LJ, Galioto A, Pineo A, Belvedere M. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res 2010;23:131-7.
129. Baker WL, Kluger J, White CM, Dale KM, Silver BB, Coleman CI. Effect of magnesium L-lactate on blood pressure in patients with an implantable cardioverter defibrillator. Ann Pharmacother 2009; 43:569-76.
130. de Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, Struyvenberg A. Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients. Diabet Med 1998;15:503-7.
131. Guerrero-Romero F, Rodríguez-Morán M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens 2009;23:245-51.
132. Henderson DG, Schierup J, Schodt T. Effect of magnesium supplementation on blood pressure and electrolyte concentrations in hypertensive patients receiving long term diuretic treatment. Br Med J (Clin Res Ed) 1986;293:664-5.
133. Borrello G, Mastroroberto P, Curcio F, Chello M, Zofrea S, Mazza M. The effects of magnesium oxide on mild essential hypertension and quality of life. Current therapeutic research. Curr Ther Res 1996;57:767-74.
134. Cohen L, Laor A, Kitzes R. Reversible retinal vasospasm in magnesium-treated hypertension despite no significant change in blood pressure. Magnesium 1984;3:159-63.
135. Plum-Wirell M, Stegmayr BG, Wester PO. Nutritional magnesium supplementation does not change blood pressure nor serum or muscle potassium and magnesium in untreated hypertension. A doubleblind crossover study. Magnes Res 1994;7:277-83.
136. Ferrara LA, Iannuzzi R, Castaldo A, Iannuzzi A, Dello Russo A, Mancini M. Long-term magnesium supplementation in essential hypertension. Cardiology 1992;81:25-33.
137. Witteman JC, Grobbee DE, Derkx FH, Bouillon R, de Bruijn AM, Hofman A. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr 1994;60:129-35.
138. Olhaberry JV, Reyes AJ, Acosta-Barrios TN, Leary WP, Queiruga G. Pilot evaluation of the putative antihypertensive effect of magnesium. Mag-Bul 1987;9:181-4.
139. Wirell MM, Wester PO, Stegmayr B. Nutritional dose of magnesium given to short-term thiazide treated hypertensive patients does not alter the blood pressure or the magnesium and potassium in muscle-a double blind cross over study. Mag-Bul 1993;15:50-4.
140. Cappuccio FP, Markandu ND, Beynon GW, Shore AC, Sampson B, MacGregor GA. Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed) 1985;291:235-8.
141. Dyckner T, Wester PO. Effect of magnesium on blood pressure. Br Med J (Clin Res Ed) 1983;286:1847-9.
142. Motoyama T, Sano H, Fukuzaki H. Oral magnesium supplementation in patients with essential hypertension. Hypertension 1989;13:227-32.
143. Widman L, Wester PO, Stegmayr BK, Wirell M. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens 1993;6:41-5.
144. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 2006;23:1050-6.
145. Rude RK. Magnesium. In: Coates PM, Betz JM, Blackman MR, Cragg GM, Levine M, Moss J, White JD, editors. Encyclopedia of dietary supplements. 2nd ed. New York: Informa Healthcare; 2010. p. 527-37.
146. Qu X, Jin F, Hao Y, Li H, Tang T, Wang H, Yan W, Dai K. Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLoS One 2013;8:e57720.
147. Chiuve SE, Sun Q, Curhan GC, Taylor EN, Spiegelman D, Willett WC, Manson JE, Rexrode KM, Albert CM. Dietary and plasma magnesium and risk of coronary heart disease among women. J Am Heart Assoc 2013;2:e000114.
148. Akarolo-Anthony SN, Jimenez MC, Chiuve SE, Spiegelman D, Willett WC, Rexrode KM. Plasma magnesium and risk of ischemic stroke among women. Stroke 2014;45:2881-6.
149. Kieboom BC, Niemeijer MN, Leening MJ, van den Berg ME, Franco OH, Deckers JW, Hofman A, Zietse R, Stricker BH, Hoorn EJ. Serum magnesium and the risk of death from coronary heart disease and sudden cardiac death. J Am Heart Assoc 2016;5.
150. Reffelmann T, Ittermann T, Dorr M, Volzke H, Reinthaler M, Petersmann A, Felix SB. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis 2011;219:280-4.
151. Misialek JR, Lopez FL, Lutsey PL, Huxley RR, Peacock JM, Chen LY, Soliman EZ, Agarwal SK, Alonso A. Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans-Atherosclerosis Risk in Communities (ARIC) study. Circ J 2013;77:323-9.
152. Khan AM, Lubitz SA, Sullivan LM, Sun JX, Levy D, Vasan RS, Magnani JW, Ellinor PT, Benjamin EJ, Wang TJ. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation 2013;127:33-8.
153. Lutsey PL, Alonso A, Michos ED, Loehr LR, Astor BC, Coresh J, Folsom AR. Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2014;100:756-64.
154. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998;136:480-90.
155. Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom AR. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2010; 160:464-70.
156. Ohira T, Peacock JM, Iso H, Chambless LE, Rosamond WD, Folsom AR. Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2009; 169:1437-44.
157. Chiuve SE, Korngold EC, Januzzi JL Jr., Gantzer ML, Albert CM. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 2011;93:253-60.
158. Ford ES. Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol 1999;28:645-51.
159. Gartside PS, Glueck CJ. The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow-up study. J Am Coll Nutr 1995;14:71-9.
160. Khan AM, Sullivan L, McCabe E, Levy D, Vasan RS, Wang TJ. Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease. Am Heart J 2010;160:715-20.
161. Leone N, Courbon D, Ducimetiere P, Zureik M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology 2006;17:308-14.
162. Marniemi J, Jarvisalo J, Toikka T, Raiha I, Ahotupa M, Sourander L. Blood vitamins, mineral elements and inflammation markers as risk factors of vascular and non-vascular disease mortality in an elderly population. Int J Epidemiol 1998;27:799-807.
163. Peacock JM, Folsom AR, Arnett DK, Eckfeldt JH, Szklo M. Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 1999;9:159-65.
164. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1999;159:2151-9.
165. Tin A, Grams ME, Maruthur NM, Astor BC, Couper D, Mosley TH, Selvin E, Coresh J, Kao WH. Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease. Kidney Int 2015;87:820-7.
166. White JR, Jr., Campbell RK. Magnesium and diabetes: a review. Ann Pharmacother 1993;27:775-80.
167. Paolisso G, Scheen A, Cozzolino D, Di Maro G, Varricchio M, D'Onofrio F, Lefebvre PJ. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994;78:1510-4.
168. Eibl NL, Kopp HP, Nowak HR, Schnack CJ, Hopmeier PG, Schernthaner G. Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy. Diabetes Care 1995;18:188-92.
169. de Lordes Lima M, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998;21:682-6.
170. Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003;26:1147-52.
171. Navarrete-Cortes A, Ble-Castillo JL, Guerrero-Romero F, Cordova-Uscanga R, Juarez-Rojop IE, Aguilar-Mariscal H, Tovilla-Zarate CA, Lopez-Guevara Mdel R. No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia. Magnes Res 2014;27:48-56.
172. Solati M, Ouspid E, Hosseini S, Soltani N, Keshavarz M, Dehghani M. Oral magnesium supplementation in type II diabetic patients. Med J Islam Repub Iran 2014;28:67.
173. Zhang X, Del Gobbo LC, Hruby A, Rosanoff A, He K, Dai Q, Costello RB, Zhang W, Song Y. The circulating concentration and 24-h urine excretion of magnesium dose-and time-dependently respond to oral magnesium supplementation in a meta-analysis of randomized controlled trials. J Nutr 2016;146:595-602.
174. Elin RJ. Determination of serum magnesium concentration by clinical laboratories. Magnes Trace Elem 1991;10:60-6.
175. College of American Pathologists. Participant summary, set C-C clinical chemistry and therapeutic drug monitoring. 2015:44-5.
176. Cohen L, Laor A. Correlation between bone magnesium concentration and magnesium retention in the intravenous magnesium load test. Magnes Res 1990;3:271-4.
177. Von Ehrlich B. Magnesiummangelsyndrom in der internistischen praxis. [Magnesium deficiency syndrome in internal medicine practice.] Magnes Bulletin 1997;19:29-30.
178. Weglicki WB, Mak IT, Kramer JH, Dickens BF, Cassidy MM, Stafford RE, Philips TM. Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res 1996;31:677-82.
179. Maier JA. Endothelial cells and magnesium: implications in atherosclerosis. Clin Sci (Lond) 2012;122:397-407.
180. Resnick LM, Gupta RK, Sosa RE, Corbett ML, Sealey JE, Laragh JH. Effects of altered dietary calcium intake in experimental hypertension: role of intracellular free magnesium. J Hypertens Suppl 1986;4:S182-5.
181. Yogi A, Callera GE, Antunes TT, Tostes RC, Touyz RM. Transient receptor potential melastatin 7 (TRPM7) cation channels, magnesium and the vascular system in hypertension. Circ J 2011;75:237-45.
182. Touyz RM. Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. Am J Physiol Heart Circ Physiol 2008;294:H1103-18.
183. Altura BM, Altura BT, Carella A, Gebrewold A, Murakawa T, Nishio A. Mg2+-Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol 1987;65:729-45.
184. Bomb R, Flatt DM, Heckle MR. Effect of cation dysregulation on corrected QT interval. J Clin Invest 2016;64(2 Suppl 1):483-94.
185. Consensus conference. Lowering blood cholesterol to prevent heart disease. JAMA 1985;253:2080-6.